Detection of translocation 8;21 on interphase cells from acute myelocytic leukemia by fluorescence in situ hybridization and its clinical application

Cancer Genetics and Cytogenetics

Volumn 113, Issue 1, 1999, Pages 29-35

  Tanaka, Kimio ^a   Arif, Mansyur ^a   Asou, Hiroya ^a   Shimizu, Kimiko ^b   Ohki, Misao ^b   Kyo, Taiichi ^c   Dohy, Hiroo ^c   Kamada, Nanao ^a  

^a Res Inst Nucl Med Biol   (Japan)

^b National Cancer Institute of Japan   (Japan)

^c ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILEUKEMIC AGENT; DAUNORUBICIN; ENOCITABINE; MERCAPTOPURINE; PREDNISOLONE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW CELL; CHROMOSOME 21; CHROMOSOME 8; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; INTERPHASE; LEUKEMIA CELL; PRIORITY JOURNAL;

ADULT; CHROMOSOMES, HUMAN, PAIR 21; CHROMOSOMES, HUMAN, PAIR 8; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DNA-BINDING PROTEINS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; LEUKEMIA, MYELOCYTIC, ACUTE; MODELS, GENETIC; PROTO-ONCOGENE PROTEINS; TIME FACTORS; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 0032838936     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(99)00011-4     Document Type: Article

References (27)

1. Miyoshi H., Shimizu K., Kozu T., Maseki N., Kaneko Y., Ohki M. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within limited region of a single gene, AML1. Proc Natl Acad Sci USA. 88:1991;10431-10434.
2. Erickson P., Gao J., Chang K.S., Look T., Whisenant E., Raimondi S., Lasher R., Trujillo J., Rowley J.D., Drabkin H. Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML-1/ETO, with similarity to Drosophila segmentation gene, runt. Blood. 80:1992;1825-1831.
3. Maseki N., Miyoshi I., Shimizu K., Homma C., Ohki M., Sakurai M., Kaneko Y. The 8;21 chromosome translocation in acute myeloid leukemia is always detectable by molecular analysis using AML1. Blood. 81:1993;1573-1579.
4. Downing J.R., Head D.R., Hulshof M.G., Motroni T.A., Raimondi S.C., Carroll A.J., Erickson P. An AML/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the t(8;21)(q22;q22) translocation. Blood. 81:1993;2860-2865.
5. Kozu T., Miyoshi H., Shimizu K., Kaneko Y., Asou H., Kamada N., Ohki M. Junction of the AML1/MTG8 (ETO) fusion are constant in t(8;21) acute myeloid leukemia detected by reverse transcription polymerase chain reaction. Blood. 82:1993;1270-1276.
6. Nucifora G., Larson R.A., Rowley J.D. Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission. Blood. 82:1993;712-715.
7. Kusec R., Laczika K., Knobl P., Friedl J., Greinix H., Kahls P., Linkesch W., Schwarzinger I., Mitterbauer G., Purtscher B. AML1/ETO fusion mRNA can be detected in remission blood samples of all patients with t(8;21) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation. Leukemia. 8:1994;735-739.
8. Maruyama F., Stass S.A., Estey E.H., Cork A., Hirano M., Ino T., Freireich E.J., Yang P., Chang K.S. Detection of AML/ETO fusion transcript as a tool for diagnosing t(8;21) positive acute myelogenous leukemia. Leukemia. 8:1994;40-45.
9. Zhang T., Hillion J., Tong J.H., Cao Q., Chen S.J., Berger R., Chen Z. AML 1 gene rearrangement and AML 1- ETO gene expression as molecular markers of acute myeloblastic leukemia with t(8;21). Leukemia. 8:1994;729-734.
10. Anastasi J., Le Beau M.M., Vardiman J.W., Fernald A.A., Larson R.A., Rowley J.D. Detection of trisomy 12 in chronic lymphocytic leukemia by in situ hybridization to interphase cells. A simple and sensitive method. Blood. 79:1992;1796-1801.
11. Arif M., Tanaka K., Asou H., Ohno R., Kamada N. Independent clones of trisomy 12 and retinoblastoma gene deletion in Japanese B cell chronic lymphocytic leukemia, detected by fluorescence in situ hybridization. Leukemia. 9:1995;1822-1827.
12. Rowley J.D., Diaz M.O., Espinosa I.R., Patel Y.D., van Melle E., van der Poel Z.S., Taillon-Miller P., Domer P.H., Le Beau M.M. Mapping chromosome band 11q23 in human acute leukemia with biotinylated probes. identification of 11q23 translocation breakpoints with a yeast artificial chromosome Proc Natl Acad Sci USA. 87:1990;9358-9362.
13. Tkachuk D.C., Westbrook C.A., Andreeff M., Donlon T.A., Cleary M.L., Suryanarayan K., Homge M., Redner A., Gray J., Pinkel D. Detection of bcr-abl fusion in chronic myelogenous leukemia by in situ hybridization. Science. 250:1990;559-562.
14. Dewald G.W., Schad C.R., Christensen E.R., Tiede A.L., Zinsmeister A.R., Spurbeck J.L., Thibodeau S.N., Jalal S.M. The application of fluorescent in situ hybridization to detect Mbcr/abl fusion in variant Ph1 chromosomes in CML and ALL. Cancer Genet Cytogenet. 71:1990;7-14.
15. Bentz M., Cabot G., Moos M., Speicher M.R., Ganser A., Lichter P., Döner H. Detection of chimeric BCR-ABL genes on bone marrow samples and blood smear in chronic myeloid and acute lymphocytic leukemia by in situ hybridization. Blood. 83:1994;1922-1928.
16. Gao J., Ertickson P., Gardiner K., Le Beau M.M., Diaz M.O., Paterson D., Rowley J.D., Darabkin H.A. Isolation of a yeast artificial chromosome spanning the 8;21 translocation breakpoint, t(8;21)(q22;q22.3) in acute myelogenous leukemia. Proc Natl Acad Sci USA. 88:1997;4882-4886.
17. Sacchi N., Magnani I., Kearney L., Wijsman J., Hagemeijer A., Darfler M. Inter-phase cytogenetics of the t(8;21)(q22;q22) associated with acute myelogenous leukemia by two-color fluorescence in situ hybridization. Cancer Genet Cytogenet. 79:1995;97-103.
18. de Greef G.E., Hagemeijer A., Morgan R., Wijsman J., Hoefsloot L.H., Sandberg A.A., Sacchi N. Identical fusion transcript associated with different breakpoints in the AML1 gene in simple and variant t (8;21) acute myeloid leukemia. Leukemia. 9:1995;282-287.
19. Paskulin G., Philips G., Morgan R., Sandberg A., Richkind K., Borovik C., McGavran L., Rabinovich N., Dietz-Band J., Erickson P., Drabkin H., Varella-Garcia M. Pre-clinical evaluation of probes to detect t(8;21) AML minimal residual disease by fluorescence in situ hybridization. Genes Chromosom Cancer. 21:1998;144-151.
20. Tashiro S., Kyo T., Tanaka K., Oguma N., Hashimoto T., Dohy H., Kamada N. The prognostic value of cytogenetic analyses in patients with acute nonlymphocytic leukemia treated with the same intensive chemotherapy. Cancer. 70:1992;2809-2815.
21. Kamada N., Dohy H., Okada K., Oguma N., Kuramoto A., Tanaka K., Uchino H. In vivo and in vitro activity of neutrophil alkaline phosphatase in acute myelocytic leukemia with 8;21 translocation. Blood. 58:1981;1213-1217.
22. ISCN (1995): An International System for Human Cytogenetic Nomenclature. F Mitelman, ed. S. Karger, Basel.
23. Aso H., Tashiro S., Hamamoto H., Otsuji A., Kita K., Kamada N. Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosome translocation. Blood. 77:1991;2031-2036.
24. Sato T, Konishi H (1996): In: Stat View 4.0 Macintosh for Experts, Bug News, Network, Tokyo.
25. Tobal K., Liu Y. Monitoring of minimal residual disease by quantitative reverse transcriptase-polymerase chain reaction for AML 1-MTG8 transcripts in AML-M2 with t(8;21). Blood. 88:1996;3703-3709.
26. Tanaka K., Arif M., Eguch M., Kumaravel T.S., Ueda R., Ohno R., Iwato K., Kyo T., Dohy H., Kamada N. Application of fluorescence in situ hybridization to detect residual leukemic cells with 9;22 and 15;17 translocations. Leukemia. 11:1997;436-440.
27. El-Rifai W., Ruutu T., Elonen E., Volin L., Knuutila S. Prognostic value of metaphase-fluorescence in situ hybridization in follow-up of patients with acute myeloid leukemia in remission. Blood. 89:1997;3330-3334.